This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Mark Cragg, PhD
Chair in Experimental Cancer Biology at University of Southampton


Mark Cragg is Professor of Experimental Cancer Biology in the School of Cancer Sciences at the University of Southampton. His research concerns how therapeutics result in tumour regression with a focus on antibodies and small molecules, with a particular interest in Fc receptors and TNFR family members. The aim is to understand how these therapeutics delete tumour cells, how resistance occurs, and how it might be overcome.

Agenda Sessions

  • Engineering Antibodies for Agonism: From Fc to Fab